A phase III study of S-1 plus cisplatin versus fluorouracil plus cisplatin in patients with advanced gastric or gastroesophageal junction adenocarcinoma.
Rui-hua Xu
No relevant relationships to disclose
Guo-ping Sun
No relevant relationships to disclose
Hui-shan Lu
No relevant relationships to disclose
Liu Yun Peng
No relevant relationships to disclose
Jian-ming Xu
No relevant relationships to disclose
Mei-zuo Zhong
No relevant relationships to disclose
He-long Zhang
No relevant relationships to disclose
Shi-ying Yu
No relevant relationships to disclose
Wei Li
No relevant relationships to disclose
Xiao-hua Hu
No relevant relationships to disclose
Jie Jun Wang
No relevant relationships to disclose
Ying Cheng
No relevant relationships to disclose
Jun-tian Zhou
No relevant relationships to disclose
Zeng-qing Guo
No relevant relationships to disclose
Zhongzhen Guan
No relevant relationships to disclose